CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79.75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Sensodyne maker Haleon cuts revenue growth forecast on weak flu season, China disruption

By Reuters News

Oct 29(Reuters) - British consumer health company Haleon HLN.L cut its annual organic revenue growth forecast on Thursday after weak demand for cold medicines and a regulatory setback in China weighed on sales.

  • The maker of Advil painkillers and Sensodyne toothpaste now expects full-year organic revenue growth of around 2.5%, down sharply from its prior forecast of 3% to 5%

  • Analysts had forecast organic revenue growth of 3.2% for 2026, according to a company-compiled poll

  • Organic revenue for the three months ended September 30 rose 2.6%, also missing market estimates of 3.2% as weaker cough, cold and flu consumption hit orders in North America, its largest market

  • Sales in China were hurt by a change in raw material classifications that affected imports of over-the-counter Centrum multivitamins, forcing Haleon to suspend shipments of the products

  • Haleon flagged a £15 million to £20 million hit to its fourth-quarter net revenue from plans to accelerate a new go-to-market model in Brazil to coincide with the country's new tax framework

  • Oral Health remained a bright spot, with sales rising 8.8% on strong demand for Sensodyne and parodontax, while emerging markets grew 5.1%, led by India


Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.